相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。FDA Approval Summary: Ruxolitinib for Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease
Donna Przepiorka et al.
ONCOLOGIST (2020)
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Qiurong Ruan et al.
INTENSIVE CARE MEDICINE (2020)
Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV
Jia Liu et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Viral load of SARS-CoV-2 in clinical samples
Yang Pan et al.
LANCET INFECTIOUS DISEASES (2020)
COVID-19: combining antiviral and anti-inflammatory treatments
Justin Stebbing et al.
LANCET INFECTIOUS DISEASES (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19
Huilan Zhang et al.
ANNALS OF INTERNAL MEDICINE (2020)
Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)
Waleed Alhazzani et al.
CRITICAL CARE MEDICINE (2020)
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Zhe Xu et al.
LANCET RESPIRATORY MEDICINE (2020)
Findings of lung ultrasonography of novel corona virus pneumonia during the 2019-2020 epidemic
Qian-Yi Peng et al.
INTENSIVE CARE MEDICINE (2020)
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
Giacomo Grasselli et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations
Jason Phua et al.
LANCET RESPIRATORY MEDICINE (2020)
Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York
Rebecca Haberman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation
F. La Rosee et al.
LEUKEMIA (2020)
Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial
Asra Ahmed et al.
LANCET HAEMATOLOGY (2019)
Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
Rudragouda Channappanavar et al.
SEMINARS IN IMMUNOPATHOLOGY (2017)
Reactive Hemophagocytic Syndrome in Adults: A Retrospective Analysis of 162 Patients
Sebastien Riviere et al.
AMERICAN JOURNAL OF MEDICINE (2014)
Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease
Silvia Spoerl et al.
BLOOD (2014)
Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms
Alfonso Quintas-Cardama et al.
BLOOD (2010)
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study
JSM Peiris et al.
LANCET (2003)
分享论文
